戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 an upturn in risk in the highest quartile of serum selenium.
2 moderate inverse relationship between plasma/serum selenium and coronary heart disease.
3                  The relation between plasma/serum selenium and prostate cancer in a nonlinear dose-r
4  were to investigate the association between serum selenium and prostate cancer risk and to examine i
5 ore the association between selenium status [serum selenium and selenoprotein P (SELENOP) concentrati
6                                     However, serum selenium, but not SELENOP or GPx3 activity, was po
7 <.001), advanced stage (P =.001), and higher serum selenium concentration (P =.032).
8 and there was an inverse association between serum selenium concentration and the proportion of oxidi
9 y was undertaken to test the hypothesis that serum selenium concentration at presentation correlates
10                                              Serum selenium concentration at presentation is a progno
11                                              Serum selenium concentration correlated closely with per
12                                          The serum selenium concentration ranged from 0.33 to 1.51 mi
13  authors explored Black/White differences in serum selenium concentration.
14 hat Blacks had lower unadjusted and adjusted serum selenium concentrations relative to Whites is intr
15                                   Crude mean serum selenium concentrations were 126.35 ng/ml for Whit
16                        Greater prediagnostic serum selenium concentrations were not associated with p
17 ma glutathione peroxidase (GPx) activity and serum selenium concentrations were performed as markers
18             Furthermore, among smokers, high serum selenium concentrations were related to reduced pr
19                                         Mean serum selenium concentrations, both crude and adjusted f
20 .01), but were not accompanied by changes in serum selenium concentrations.
21  with FEV1 in smokers than nonsmokers, while serum selenium had a stronger positive association with
22                                              Serum selenium in prospectively collected samples was co
23                                   Changes in serum selenium in the intervention group were associated
24                      The association between serum selenium levels and the prevalence of peripheral a
25 disease prevalence decreased with increasing serum selenium levels up to 150-160 ng/mL, followed by a
26 ients with sepsis syndrome commonly have low serum selenium levels.
27 l arterial disease decreased with increasing serum selenium (P for linear trend = 0.02), but there wa
28                         Adjustment for known serum selenium predictors, including a proxy for residen
29                                              Serum selenium, SELENOP, and GPx3 activity were measured
30 at the risk decreased with increasing plasma/serum selenium up to 170 ng/mL.
31 r risk (P for trend = 0.70); however, higher serum selenium was associated with lower risks in men re
32                                              Serum selenium was measured by using inductively coupled
33 t baseline, in fully adjusted models, higher serum selenium was nonlinearly associated with global co
34                                     Overall, serum selenium was not associated with prostate cancer r
35 h crude and adjusted for known predictors of serum selenium, were determined for 10,779 Black and Whi
36  cross-sectional study of the association of serum selenium with the prevalence of peripheral arteria